Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.86 USD | +8.09% | +6.83% | -18.47% |
02:56pm | Intellia Therapeutics' Q1 Net Loss Narrows, Collaboration Revenue Rises | MT |
Apr. 15 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
MarketScreener Editorial Features
Today on Wall Street: The start of a new phase | June 30, 2021 at 08:47 am EDT | |
ANALYST RECOMMENDATIONS : Apple, FedEx, Intellia Therapeutics, Reckitt Benckiser, XPO Logistics... | June 30, 2021 at 06:12 am EDT |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.
- MarketScreener Editorial Features